Article: The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy in Cancer Cell

By Matheus Henrique Dias, Chrysa Papagianni, Rene Bernards

Volume 42, Issue 6, 10 June 2024, Pages 919-922

Most targeted cancer drugs inhibit the oncogenic signals to which cancer cells are addicted. We discuss here a counterintuitive approach to cancer therapy, which consists of deliberate overactivation of the oncogenic signals to overload the stress responses of cancer cells. We discuss why such overactivation of oncogenic signaling, combined with perturbation of the stress response pathways, can be potentially effective in killing cancer cells, aiming to inspire further discussion and consideration.

See the full article from the Cancer Cell journal on Science Direct >>